Federal Register of Legislation - Australian Government

Primary content

PB 42 of 2010 Specifications as made
This Specification determines pharmaceutical benefits that can be resupplied inside 20 days on the one prescription.
Administered by: Health
Registered 28 Apr 2010
Tabling HistoryDate
Tabled HR11-May-2010
Tabled Senate11-May-2010
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 42 of 2010

National Health Act (Pharmaceutical Benefits – Early Supply) Amendment May 2010 - Specification Under Subsection 84AAA(2)

 

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

 

I, Felicity McNeill, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

 

Dated 19 April 2010

 

 

FELICITY MCNEILL

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

 

 

 

Amendment determination — Pharmaceutical Benefits - Early Supply

 

 

1          Name of Instrument

 

(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment May 2010 - specification under subsection 84AAA(2).

 

(2)           This Instrument may also be cited as “No. PB 42 of 2010”.


 

2          Commencement

 

This Instrument commences on 1 May 2010.

 

 

3          Amendment of PB 30 of 2009

 

Schedule 1 amends the National Health Act (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.

 


Schedule 1        Amendments

[1]                                  Schedule 1, item dealing with Gliclazide

Omit from the columns in the order indicated:

 

Gliclazide

Tablet 60 mg (modified release)

Oral

60

5